← Evidence map

ArticleCell death and differentiation2026

Targeting ADAR1 lactylation activates innate immune and overcomes chemoresistance in ovarian cancer.

Linlu Cui et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42185630